Analyst Observations
Published: May 6, 2025
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Comments include: BRBR, HCA, & WLFC.

 

BRBR BellRing Brands Inc. ($63.77) - Food Beverages/Soap - Shares of BRBR plummeted after disappointing earnings on Tuesday, returning the stock to a sell signal. The previous 5 for 5’er reversed into a column of Xs on its market RS chart while its peer RS chart may do so overnight. The stock remains ok to hold for now, but further deterioration, such as flipping into a negative trend, would bring it out of acceptable territory. The stock is nearing slightly oversold territory with today’s move, holding an intraday OBOS reading around -60%. It now sits right above support at $64 with its bullish support line at $55. Previous resistance in the low $60s could serve as potential bounce points as well.
HCA HCA Healthcare Inc. ($356.70) - Healthcare - HCA inched higher to break a double top at $352, marking its second consecutive buy signal. The 5 for 5’er moved into a positive trend last month and has been on a market buy signal since 2012. Additionally, HCA ranks in the top half of the healthcare sector matrix. The weight of the technical evidence is positive. Long exposure can be considered here. Initial support is at $328, also the general location of the newly established bullish support line.
WLFC Willis Lease Finance Corp. ($130.13) - Aerospace Airline - WLFC moved lower today on poor earnings, tumbling as much as 17% for the day. The stock moved down to a weak attribute name to start April and has now shed roughly 37% of its value so far this year. The move posts fresh 2025 lows and brings the name back down below a range of resistance in the mid $140's the stock fought valiantly to move back. Continue to avoid.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-{ENDYEAR} Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright